XML 20 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Operating activities:    
Net loss $ (29,376) $ (21,914)
Adjustments to reconcile net loss to net cash used by operating activities:    
Depreciation and amortization expense 909 815
Non-cash interest 952 523
Stock-based compensation 1,103 990
Provision for bad debt expense 1,334 0
Loss on debt extinguishment 0 1,333
Changes in operating assets and liabilities:    
Accounts receivable 1,709 (1,486)
Inventory (3,612) (1,886)
Prepaid expenses and other current assets (566) 98
Accounts payable 925 1,042
Accrued expenses and contract liabilities 412 337
Net cash used in operating activities (26,210) (20,148)
Investing Activities:    
Lineagen acquisition, net of cash acquired (2,450) 0
Purchases of property and equipment 0 (38)
Net cash used in investing activities (2,450) (38)
Financing activities:    
Proceeds from issuance of term debt, net of issuance costs 0 19,169
Repayment of term-loan debt (5,000) (10,812)
Proceeds from PPP Loan 1,775 0
Proceeds from borrowing from line of credit 761 3,084
Repayments of borrowing from line of credit (2,258) (2,131)
Proceeds from sale of common stock, net of offering costs 16,366 2,410
Proceeds from sale of common stock under employee stock purchase plan 21 103
Proceeds from warrant and option exercises 18,551 65
Net cash provided by financing activities 30,216 11,888
Net decrease in cash and cash equivalents   (8,298)
Cash and cash equivalents at beginning of period 17,311 16,523
Cash and cash equivalents at end of period 18,867 8,225
Supplemental cash flow disclosures:    
Cash paid for interest 991 1,036
Supplemental disclosure of non-cash investing and financing activities:    
Fair value of common stock issued related to Lineagen acquisition 4,100 0
Property and equipment costs incurred but not paid included in accounts payable and accrued expenses 0 8
Fair value of warrants issued with debt 0 630
Transfer of instruments and servers from property and equipment into inventory 134 360
Transfer of instruments and servers from inventory to property and equipment 2,618 0
Issue common stock for covenant waiver 300
Fair value of stock issued with debt 0 202
Deferred equity issuance costs in accounts payable and accrued liabilities 0 197
Debt issuance costs in accounts payable and accrued liabilities $ 0 $ 35